Brief: GreenLight (ENVI) And IAVI Begin Work On Omicron Variant-Adapted COVID-19 Vaccine Candidate
Dec 3 (Reuters) -
* GREENLIGHT (ENVI) AND IAVI BEGIN WORK ON OMICRON
VARIANT-ADAPTED
COVID-19 VACCINE CANDIDATE
Source text for Eikon: ID:nPn5ZbNMMa
Further company coverage: ENVI.O
Recent news on Greenlight Biosciences Holdings PBC
See all newsBrief: Greenlight Biosciences To Cut Workforce By About 51%
U.S. RESEARCH ROUNDUP-Microsoft, Chevron, Carisma Therapeutics
U.S. STOCKS ON THE MOVE-Netflix, Hewlett Packard Enterprise, Digital Realty
U.S. STOCKS ON THE MOVE-AI stocks, Broadcom, T2 Biosystems
GreenLight Biosciences gains on deal to be acquired by Fall Line Capital